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A u t o s o m a l  d o m i n a n t  c e r e b e l l a r  
a t a x i a  w i t h  r e t i n a l  d e g e n e r a t i o n :
C l i n i c a l ,  n e u r o p a t h o l o g i c ,  a n d  g e n e t i c  a n a l y s i s  
o f  a  l a r g e  k i n d r e d
L.G. Gouw, BA; K.B. Digre, MD; C.P. Harris, MD; J.H. Haines, MD; and L.J. Ptacek, MD
Article a b s tra c t—The autosomal dominant cerebellar ataxias (ADCA) comprise a heterogeneous group of neurologic 
disorders characterized by degeneration of the cerebellum, spinal cord, and brainstem . Genetic analysis has revealed 
two loci, SCA1 on chromosome 6p, and SCA2 on chromosome 12q, responsible for some ADCA. We present a four-gen­
eration kindred of 42 individuals, 12 of whom were clinically affected with ADCA and an associated cone dystrophy. 
Early loss of color discrimination with retinal and macular signs is followed by gradual progression of cerebellar dys­
function and development of pyramidal signs. Pathology shows degeneration of cerebellum, basis pontis, inferior olive, 
and retinal ganglion cells. For genetic analysis, we used polymorphic m arkers D6S89 and D12S79; linkage analysis 
gave negative results, excluding linkage to both SCA1 and SCA2. The data strongly support genetic heterogeneity con­
sistent with the unique clinicopathologic features of the form of ADCA displayed in this large family.
NEUROLOGY 1994;44:1441-1447
Autosomal dominant cerebellar ataxias (ADCA) in­
clude an array of clinical presentations: phenotypes 
include ataxia, dysarthria, dysmetria, dysdiadochoki- 
nesia, and intention tremor. There is progressive de­
generation of the cerebellar cortex, and in certain 
subtypes, associated degeneration occurs in other 
structures including the cerebellar nuclei, basis pon­
tis, inferior olivary nuclei, spinal cord, peripheral 
nerves, basal ganglia, optic nerve, and retina. The 
nosology is further complicated by variability in 
severity, age at onset, and progression, even within 
families. There are various schemes of clinical classi­
fication using a variety of criteria,1'3 but none has 
been found wholly satisfactory, as all relate to pheno­
types that are clinically heterogeneous. A more pre­
cise resolution of the underlying cause of the specific 
disorders requires characterization at the genetic 
and molecular level.4 Recent linkage studies are be­
ginning to unravel the tangled and often overlapping 
array of ADCA classification schemes; in a number of 
kindreds affected status can be associated with a spe­
cific genomic site. Currently, disease loci for ADCA 
designated “spinal cerebellar ataxia 1 and 2” (SCA1 
and SCA2) have been localized. SCA1 lies on the 
short arm of chromosome 6 and is associated with a
number of families with ADCA.5 6 A large Cuban kin­
dred with features clinically indistinguishable from 
SCA1 families exists7; the disease locus in this fam­
ily, SCA2, lies on the long arm of chromosome 12.8
A form of ADCA exists that is clinically similar to 
SCA1- and SCA2-linked families but is distinguished 
by associated macular and retinal degeneration, 
manifested as early loss of color discrimination fol­
lowed by progressive ataxia and loss of vision. Since 
its initial description as a distinct clinical entity,9 a 
number of families showing concurrent spinocerebel­
lar and retinal degeneration have been described.1016 
We present a large family with this form of ADCA 
and describe clinical and pathologic findings, along 
with results of pairwise linkage analysis with genetic 
markers associated with SCA1 and SCA2.
M ethods. Kindred. Observations are based on kindred 
1793, a family of four generations with 55 members. Forty- 
two of these family members were examined by one of the 
authors (K.D., J.H., or L.P.). Family members underwent a 
complete general neurologic examination, particularly of 
extraocular muscle and cerebellar function, with special a t­
tention to saccades, visual pursuit, appendicular coordina­
tion, rapid alternating movements, gait, and Romberg test-
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Figure 1. Pedigree o f kindred 1793. Data were obtained 
from individuals with nonhyphenated numbers; the 
proband is 13180. Darkened circles (females) and 
squares (males) represent clinically affected people. 
Shaded icons represent asymptomatic at-risk 
individuals, considered clinically unknown for linkage 
purposes. White icons represent asymptomatic 
individuals considered unaffected due to age >50 or 
status as spouse o f a fam ily member. Genotypes for 
markers D6S89 (top) and D12S79 (bottom) are shown 
beneath each icon.
ing. A complete eye examination was performed for all af­
fected or at-risk individuals and included visual acuity 
measured with the Snellen eye chart and color vision as­
sessment with the Farnsworth dichromatous (D15) stan­
dardized color-chip test and color plates. Retinal examina­
tion included both direct and indirect ophthalmoscopy, 
macular and retinal photographs, and whenever possible 
electroretinography (ERG). The pedigree is shown in figure 
1. A detailed family history was obtained through personal 
interviews with available family members. Twelve were 
clinically affected. Because of the variable onset of this dis­
order, at-risk family members were considered unaffected 
only if neurologic and ophthalmologic examinations were 
completely normal after age 50. Only one at-risk family 
member met these criteria (13218). Spouses marrying into 
the family were also considered unaffected. For the pur­
pose of linkage analysis, the affection status of asymp­
tomatic at-risk individuals under the age of 50 was consid­
ered unknown.
Anticoagulated venous blood samples obtained from the 
examined individuals were used for direct DNA prepara­
tions and to establish lymphoblastoid cell lines by Epstein- 
Barr virus transformation as previously described.17 Sub­
jects (or, in the case of minors, the responsible adult) 
signed a “Consent for Participation” form which was ap­
proved by the Institutional Review Board for Human Re­
search at the University of Utah School of Medicine.
DNA isolation and marker analysis. High molecular- 
weight genomic DNA was isolated from whole blood lysate 
w ith  a phenol/chloroform  ex traction  followed by iso- 
propanol precipitation .18 Genetic evaluation was under­
taken in the four-generation kindred using markers that 
are tightly linked to the SCA1 and SCA2 loci. End-labeled 
primers (D6S89a or D12S79a) were prepared as follows: 25 
pmol primer, 50 mM TRIS HC1, 10 mM MgCl2, 5.0 mM 
dithiothreitol, 8.4 U of T4 polynucleotide kinase, and 6.0 |jl 
[7-32P] ATP (5 mCi/ml), in a total volume of 10 pi. This mix­
ture was incubated at 37 °C for 30 minutes and was then 
heated to 95 °C for 2 minutes to inactivate the T4 polynu­
cleotide kinase.
The polymerase chain reaction (PCR) was used to am­
plify total genomic DNA using primers flanking polymor­
phic regions known to be tightly linked to loci a s s o c i a t e d  
with ADC A. The reaction mixture contained 100 ng of ge­
nom ic DNA, 10 pm ol of each  p rim e r (D 6S89a and 
D6S89b, or D12S79a and D12S79b), 1 pmol of the end-la­
beled primer (D6S89a or D12S79a), 2.5 nmol of each de- 
oxynucleoside triphosphate, 10 mM TRIS HC1 (pK 8.4), 
40 mM NaCl, 1.5 mM MgCl2, and 0.5 U Taq DNA poly­
merase in a volume of 25 pi. PCR was carried out under 
the following conditions: (1) one cycle at 94 °C for 4  min­
utes; (2) 30 cycles, each at 94 °C for 1 minute, Tannea] for 1 
minute, and 72 °C for 1 minute; and (3) cooling to 4 °C. 
Tajmeal was 54 °C for D6S89 and 58 °C for D12S79. After
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Clinical features
Age a t onset 
(range)















Dull m entation  
Pathology
K in d re d  1793
(12-53)
H ighly variable 







B abinski present 
+ 
+








O phthalm oparesis/nystagm us,6 
occasional nystagm us5
Babinski p resen t 
+
+6/-5
SCA2  k in d r e d 7
(2-65)
V ariable (7-20)






Atrophy of Purk in je  cells, 
granule cells, den ta te  nuclei, 
inferior olive, basis pontis, 
re tina l ganglion cells, la tera l 
geniculate nuclei, spinocere­
bellar tracts, and middle cere­
bellar peduncle; m ild loss of 
posterior funiculus and sub­
s tan tia  nigra
Atrophy of Purk in je  cells, cere­
bellum, inferior olive; variable 
pontine and  spinal cord involve­
m ent; changes in  spinocerebellar 
tracts, posterior funiculus, and 
CN IX, X, and  XII nuclei6 
A trophy of P urk in je  cells, w hite 
m a tte r of cerebellum , inferior 
olive, basis pontis, CN XII nuclei, 
dorsal columns, and  spinocere­
bellar tra c ts5
Atrophy of Purkinje cells, esp. neo/ 
paleocerebellar cortices; den ta te  
nuclei intact; atrophy of inferior 
olive, pontine nuclei, substan tia  
nigra; m arked  dem yelination of 
posterior funiculus, m oderate 
loss of spinocerebellar tra c t27
+ P resen t. 
-  A bsent.
PCR, 5 pi of stop dye (98% formamide, 0.05% bromophenol 
blue, 0.05% xylene cyanol, and 20 mM EDTA) was added. 
Four pi of each sample were then loaded on a 7% acryl- 
amide gel th a t contained 5.6 M urea, 32% formamide, 90 
mM TRIS borate (pH 7.5), and 2 mM EDTA. Pre-elec­
trophoresis of gels (1 hour prior to loading) and elec­
trophoresis were performed a t room tem perature and at 
constant power (80 W/gel) with 90 mM TRIS borate (pH 
7.5) and 2 mM EDTA running buffer. Gels were placed on 
filter paper and exposed to x-ray film overnight at —80 
°C. Autoradiograms were analyzed for genotypes of the 
polymorphic alleles. With D6S89, nine alleles were ob­
served between 199-225 bp. D12S79 showed seven alleles 
between 149-169 bp.
Statistical analysis. Using maximum-likelihood meth­
ods, we performed pairw ise linkage analysis w ith the 
MLINK program of the LINKAGE system .19 We calcu­
lated two-point analysis of the m arkers to the disease 
locus at a penetrance of 0.95. A gene frequency of 0.001 
was assigned to the disease allele and 0.999 for the normal 
allele.
Results. Clinical findings. Clinical features are sum­
marized in table 1. For comparison, clinical features 
are also shown for patients in ADCA kindreds known 
to be linked to SCA1 and SCA2. Three patients with 
different stages of disease are described, illustrating 
the range and clinical variation in severity, age at 
onset, and progression.
P a tie n t 13180. The proband first noted visual loss at age 
13. By age 16, she began to have problems with stability 
and ba lance . T his p ro g ressed  to th e  p o in t w here a 
wheelchair was required at age 25. Physical examination 
at age 28 showed visual acuity without correction to be lim­
ited to only light perception; pupils were 8 mm in darkness 
bilaterally and 7 mm in light bilaterally, showing no rela­
tive afferent pupillary defect. She had 45 diopters of exo- 
trop ia by the K rim sky rule. E xtraocular m otility was 
markedly diminished in all directions except downgaze, 
w here m oderate  lim ita tio n  was noted. A Bell’s p h e­
nomenon was demonstrated, which showed better up-gaze
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Figure 2. Funduscopic photo of the proband (13180) 
shows changes seen in the late stage of the disease. There 
is extreme macular degeneration with rare dot 
hemorrhages.
than voluntaiy gaze. ERG testing showed absent A and B 
waves. Slit-lamp examination disclosed a normal anterior 
segment. The fundus showed large atrophic areas in the 
macula and rare dot hemorrhages adjacent to the arcades 
su rro u n d in g  th e  m acu la  (figure 2). Saccades w ere 
markedly slow. Slight weakness in eye closure and hyper­
active gag were noted. Muscle tone was m arkedly in ­
creased, with motor strength rated 5/5. Upper-extremity 
reflexes were +3 to +4 with bilateral ankle clonus and tonic 
b ilateral B abinski signs. Finger-to-nose was slow and 
ataxic, heel-to-shin was completely dysmetric, and alter­
nating rapid movements were slow and ataxic bilaterally. 
Speech was markedly dysarthric. Sensation was normal 
throughout. By age 29, there was minimal papillary light 
reflex w ith v irtual absence of extraocular movements. 
Disks showed pallor and large atrophic scars around the 
macula. Examination demonstrated bilateral facial weak­
ness and truncal titubations. She died at the age of 31 of 
pneumonia and respiratory compromise secondary to pro­
gression of the disease.
P a tie n t 13174. The father of the proband first noted an 
episode of double vision at age 30. Subsequent visual ex­
amination showed acuity of 20/25 bilaterally with correc­
tion; night vision was less impaired. Progressive photopho­
bia was noted. At age 33 he noted ataxia, particularly 
when running, which progressed to frequent stumbling 
and awkward gait while walking. Around this time he also 
noticed speech difficulty, speaking in a hoarse whisper 
with progressive dysarthria. He denied hearing problems, 
dizziness, numbness, or paresthesia. Physical examination 
at age 58 showed visual acuity of 20/400, which could be 
corrected to 20/300 in both eyes. Color-plate testing re ­
vealed inability to see any color and on D15 testing, ability 
to see only a mixed shade of gray. Pupils were 6 mm and 
sluggishly reactive to light. Extraocular movements were 
impaired, especially up-gaze. Vestibular ocular reflex was 
intact. Pursuit was fair, but saccades were slowed. Visual 
fields were full to confrontation in the periphery, with cen­
tra l scotoma. Slit-lamp examination disclosed mild nu­
clear sclerosis. Corneal reflex was present but gag reflex 
was decreased bilaterally. Motor strength  was norm al
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with increased tone; reflexes were hyperactive, and a U I 
clonus was presen t bilaterally. Babinski and Hoff11 > 
signs were present. Marked dysdiadochokinesis, im p^an 
rapid a lte rn a tin g  movements, and heel-to-shin ata ' 
were present. Funduscopic examination revealed disk n ?  1 
lor and granular changes in the macula. ERG showed h 
sent photopic response and a present but reduced scoton 
response. l^c
P a tie n t 13271. The sister of the proband noticed increas 1 
ing vision problems primarily characterized as difficult 
with driving and seeing signs at age 29. By age 30 she no 
ticed problems with her gait, especially after prolonged 
inactivity. Physical examination a t age 31 showed best 
corrected visual acuity to be 20/60-2 and 20/70-2. Color- 
plate acuity was significantly reduced bilaterally, Dl5 
color testing  showed a defect in the tritan  axis. Fields . 
were normal, extraocular movements were full, and fun­
dus was normal. Saccades were slowed. Reflexes were 
brisk but no clonus was present. P lan tar reflexes were 
equivocal. Motor strength was normal. Finger-to-nose and 
heel-to-shin were fair, and rapid alternating movements 
were good. A hint of dysarthria was noted in her speech 
Tandem gait was normal, but she was somewhat clumsy 
in hopping on one foot. Visual field examination and ERG * 
were entirely normal. 1
Autopsy findings. At autopsy of the proband, the I 
most striking features were present upon neu- 
ropathologic examination. The cerebral hemispheres 
demonstrated no atrophy grossly. However, all of the i 
posterior fossa structures were severely atrophic (fig­
ure 3), with the cerebellum, pons, and medulla being 
only about half of their normal expected size. Multi­
ple coronal sections through the cerebral hemi- i 
spheres were unremarkable, but axial sections 1 
through the cerebellum and brainstem revealed 
shrunken, discolored cerebellar folia, symmetric thin- j 
ning of the middle cerebellar peduncles, and atrophic 
inferior olivary nuclei. The caliber of the spinal cord ! 
was also diminished.
Light microscopic examination with hematoxylin- 
eosin staining revealed normal cerebral cortices and 
basal ganglia. The lateral geniculate nuclei demon­
strated severe neuronal loss and accompanying glio- ! 
sis. Mild to moderate neuronal dropout was present i 
in the substantia nigra with a reactive astrocytosis. 
Sections of the cerebellum confirmed near-total loss . 
of the dentate nucleus neurons with an underlying 
gliosis. The cerebellar folia exhibited severe Purkinje 
cell loss with an accompanying Bergmann gliosis, 
granular cell dropout, and thinning of the white mat­
ter. The pontine tegmentum was normal, but the 
basis pontis was shrunken with diffuse loss of pon­
tine neurons, and the white matter tracts were 
thinned. Near-complete loss of the neuronal popula­
tion of the inferior olivary nuclei was seen with dif­
fuse astrocytosis. Sections of the spinal cord demon- . 
strated mild tract degeneration in the posterior 
columns and more significant loss of both dorsal and i 
ventral spinal cerebellar tracts most prominent in 
the cervical region.
Sections of the eyes at autopsy showed a normal 



























































T able 2. Log o f th e  o d d s (lod) sco re  tab le  fo r 
p a irw ise  lin k ag e  b e tw een  k in d re d  1793 an d  
m a rk e rs  k n o w n  to  be a sso c ia te d  w ith  au to so m al 
d o m in an t sp in o c e re b e lla r  a ta x ia  loci SCA1  
(D6S89) a n d  SCA2  (D12S79)*
Figure 3. Gross section o f the posterior fossa of the 
proband taken a t autopsy shows striking atrophy. The 
patient’s section at the top is contrasted with the age- 
matched control below, showing marked degeneration of 
the pons and anterior vermis. Shrunken, discolored 
cerebellar folia, atrophy o f the inferior olivary nuclei, and  
diminished spinal cord caliber were also present grossly.
rior changes included numerous cobblestone-like, 
deep pigmented areas in a circumferential pattern at 
the level of the pars plana and ora serrata, some with 
a dark brown central pigment clump. No obvious 
retinal vasculature was apparent. The macula ap­
peared to have a central cavity. The optic nerve head 
appeared very pale and atrophic.
Microscopic examination of the retina demon­
strated diffuse, extensive degeneration of the photo­
receptor cell layer, as well as absence of much of the 
outer nuclear layer throughout. Focal areas of abrupt 
discontinuity of the retinal pigment epithelium were 
noted. The choroid appeared to be uninvolved. The 
optic nerve showed early atrophic changes. Autopsy 
findings are summarized at the bottom of table 1 and 
contrasted with pathologic observations in kindreds 
linked to the SCA1 and SCA2 loci.
Genetic analysis. Linkage results between kindred 
1793 and D6S89 (a chromosome 6p marker with 2% 
recombination with locus SCAD  and D12S79 (a chro­
mosome 12q marker with 4% recombination with 
locus SCA2) are summarized in table 2. Pairwise log 
of the odds (lod) scores were calculated at a pene­
trance of 0.95. Lod scores are given for various re­
combination fractions for each marker under strict 
diagnostic criteria with 12 clinically affected, nine
Lod score  a t  reco m b in a tio n  frac tio n
M ark er 0% 1% 5% 10% 20% 30% 40%
D6S89 -1.34 -1.31 -0.81 -0.34 0.08 0.18 0.14
D12S79 -8.09 -5.00 -3.21 -2.03 -0.91 -0.41 -0.14
Simulation 3.37 3.31 3.06 2.75 2.06 1.33 0.60
* Results are based on a conservative estimate of disease frequency 
of 0.001. An assumed penetrance of 95% and sex-averaged recom­
bination fraction were used. Family members' affection status is 
described in figure 1. Data assumes 12 affected, nine unaffected, 
and 21 unknown at-risk family members.
unaffected, and 21 individuals of unknown pheno­
type. Under these conditions, with 95% penetrance, 
lod scores for marker D12S79 are less than - 2  from 
zero to 10% recombination, excluding the disease al­
lele from a 20-cM region around the marker. Reduc­
ing the penetrance to 70% also gave consistently neg­
ative data (data not shown). In contrast, in a simula­
tion run where the disease phenotype cosegregates 
with an optimal two-allele marker, a maximum po­
tential lod score of 3.37 at zero recombination can be 
generated with kindred 1793. The disparity between 
the maximum potential lod scores and those gener­
ated by marker D12S79 indicates that linkage of the 
disease seen in kindred 1793 to SCA2 is highly un­
likely. Although lod scores for marker D6S89 were 
greater than - 2 , all values remained negative from 
zero to 17% recombination. Furthermore, the exis­
tence of at least two obligate recombinants between 
the disease and a marker known to lie within 2 cM of 
SCA1 make linkage in kindred 1793 to this locus un­
likely as well.
D iscussion. Members of our four-generation family 
had ADCA and retinal degeneration. The disease 
was characterized by early visual deficits followed by 
deteriorating vision and progressive limb and gait 
ataxia. Investigation of the family outlined the spec­
trum of signs and symptoms from asymptomatic loss 
of color discrimination with macular signs to com­
plete blindness and disabling ataxia. D15 color-chip 
testing demonstrated abnormalities in all affected in­
dividuals; the defects were all in the tritan color axis 
(yellow-blue), a very rare dichromatic deficiency. 
Other clinical m anifestations included severe 
dysarthria, dysmetria, dysdiadochokinesia, ophthal­
moplegia, and upper motor neuron signs. Severity 
and age of onset varied considerably. Anticipation 
may have been present, with earlier generations ex­
hibiting milder signs and later onset and subsequent 
generations showing earlier onset with more dra­
matic changes.
Many of the posterior fossa findings were similar 
to those in other subgroups of multisystem atrophy. 
Pathology included neuronal loss in the inferior oli­
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vary nuclei and basis pontis; cerebellar neuronal loss 
included Purkinje cells, granule cells, and neurons of 
the dentate nuclei. Corresponding tract atrophy in­
cluded mild loss of the posterior funiculus of the 
spinal cord and more significant loss of the spino­
cerebellar fibers and middle cerebellar peduncles. 
The distinctive feature of this ADCA subtype was the 
severe loss of the photoreceptor layer and ganglion 
cells in the retina along with atrophic changes of the 
optic nerve.
A number of families with ADCA are linked to 
HLA and genetic markers on the short arm of chro­
mosome 6.5’20'23 SCA1 is the designated disease locus 
for this form of spinocerebellar ataxia. SCA1 lies in 
region 6p23.05-p24.2,24 within 2 cM of polymorphic 
marker D6S89,25 a microsatellite GT-repeat useful 
for linkage due to its proximity, ease of PCR-based 
analysis, and high informativeness.2® SCA1 is linked 
to families with ADCA without peripheral involve­
ment as well as to families exhibiting a form of 
ADCA notable for associated cranial nerves IX, X, 
and XII palsies (olivopontocerebellar atrophy type IV, 
Schut-Haymaker type).6 This implies two distinct 
disorders that are tightly linked and may be allelic. 
However, enough similarities exist between these 
families for variations in sampling between inves­
tigative groups to account for the described pheno­
typic differences.
Genetic analysis of other kindreds with members 
exhibiting a clinically indistinguishable form of 
ADCA7’27’28 excluded linkage to SCA i,28-29 providing 
evidence of genetic heterogeneity despite clinical ho­
mogeneity. Further studies with a large Cuban 
ADCA kindred7 27 localized another disease locus, 
SC A2, to the chromosome 12q23-q24.1 region,8 
flanked by the phospholipase A2 gene and within 4 
cM of another highly inform ative polymorphic 
marker, D12S79. A summary of clinical and patho­
logic features is outlined in table 1.
Two-point linkage analysis between the disease 
phenotype in kindred 1793 and the aforementioned 
markers, known to be associated with ADCA, gave 
negative lod scores for tight linkage to both D6S89 
and D12S79. The data outlined in table 2 exclude the 
disease locus from both candidate regions on chromo­
somes 6p and 12q and provide evidence that the dis­
ease seen in kindred 1793 is a distinct entity both 
phenotypically and genetically, despite the many 
similarities in clinical presentation and pathology to 
SCA1- and SCA2-linked families. This is a necessary 
prelude for the eventual characterization of a third 
genomic locus associated with this unique clinico- 
pathologic presentation. Further genetic analysis 
should eventually yield a chromosomal region associ­
ated with the phenotype in kindred 1793. Numerous 
highly polymorphic PCR-based markers exist and 
new markers continue to become available, making a 
general linkage search of the entire human genome 
feasible with a well-defined kindred of this size.
The anticipation in this and other families with 
similar findings is interesting in light of discoveries 
that there is a genetic basis for this phenomenon in a
number of inherited diseases, such as spinal bulb- 
muscular atrophy, fragile X syndrome, myotonic dv* 
trophy, and Huntington’s disease, in the form of ge^  
erationally expanding hypervariable trinucleotide re 
peat regions.30 35 Furthermore, the disease phenotyn 
for SCA1-linked families is associated with an ex­
panding trinucleotide repeat in the SCA1 region; the 
repeat is transcribed to a 10-kilobase mRNA product 
found in numerous tissues.36 As in the other diseases 
associated with trinucleotide repeat expansions, the 
size of the expansion correlates with the severity of 
the disease. A similar region affecting cell-specific 
gene function or expression would explain the vari­
able clinical presentation in this family and may aid 
in the isolation of the gene. Genetic characterization 
will not only allow for unambiguous classification of 
the disease entity and provide the basis for presymp- 
tomatic screening but should also provide valuable 
insight in the study of both spinocerebellar and reti­
nal degeneration.
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